Certified by Founder
Lodge
Gradient Denervation Technologies
start up
Switzerland
- Basel
- 08/09/2023
- Series A
- $15,015,000
A solution for patients suffering from heart failure with pulmonary hypertension.
- Industry Medical Device
- Website https://www.gradientdenervation.com/
- LinkedIn https://www.linkedin.com/company/gradient-denervation-technologies/about/
Related People
Martin GrasseFounder
Switzerland -
Basel, Basel
Medical device professional focused on advancing patient care through innovation. Focused on the convergence of unmet clinical needs, new gadgets and compelling business models.
NcodiN | $18,456,480 | (Nov 21, 2025)
Voio | $8,600,000 | (Nov 21, 2025)
Stuut | $29,500,000 | (Nov 21, 2025)
Made Card | $8,000,000 | (Nov 21, 2025)
Poly(US) | $8,000,000 | (Nov 21, 2025)
Runlayer | $11,000,000 | (Nov 21, 2025)
AI Proteins | $41,500,000 | (Nov 21, 2025)
Automat | $15,500,000 | (Nov 21, 2025)
EQORE | $1,700,000 | (Nov 21, 2025)
Poppy Flowers | $2,700,000 | (Nov 21, 2025)
WellBeam Inc | $10,000,000 | (Nov 21, 2025)
Revenium | $13,500,000 | (Nov 21, 2025)